5,541 clinical studies from Jan, 2015 to Dec 14, 2017: Govt

Image
Press Trust of India New Delhi
Last Updated : Dec 19 2017 | 10:35 PM IST
A total of 5,541 clinical studies were registered in the Clinical Trials Registry-India (CTRI) from January, 2015 to December 14, 2017, the Rajya Sabha was informed today.
Union Minister of State for Health Ashwini Kumar Choubey in a written reply to a question said clinical trials of new drugs are regulated under Rules 122DA, 122DAB, 122DAC, 122DD and Schedule-Y of the Drugs and Cosmetics Rules, 1945.
"Clinical trials are required to be conducted as per the approved protocol and Good Clinical Practices (GCP) guidelines published by the Central Drugs Standard Control Organisation (CDSSCO)," he said.
"The number of clinical studies registered in the Clinical Trials Registry-India (CTRI) from January, 2015 to December 14, 2017 is 5,541," the minister said.
Further, in May 2017, the Indian Council of Medical Research (ICMR) has become a signatory to the WHO joint statement regarding results disclosure within one year of trial completion, he said.
"The statement commits to have in place a mechanism within one year to implement the same," Choubey added.

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Dec 19 2017 | 10:35 PM IST

Next Story